mbGM-CSF tumor vaccines (IRC)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamembGM-CSF tumor vaccines (IRC)
Drug Alias Namemelanoma vaccine (IRC)prostate cancer vaccine (IRC)genetically engineered cancer cell line therapy (IRC)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Response Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune Response Biopharma Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A